Page last updated: 2024-12-11

tiliroside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tiliroside: isolated from seeds of Eremocarpus setigerus [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5320686
CHEMBL ID266564
CHEBI ID80944
SCHEMBL ID23597
MeSH IDM0147990

Synonyms (51)

Synonym
MEGXP0_000169
2-propenoic acid, 3-(4-hydroxyphenyl)-, 6'-ester with 3-(beta-d-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
20316-62-5
kaempferol-3-o-(6-o-trans-p-coumaroyl)-.beta.-glucopyranoside
tiliroside
4h-1-benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[[6-o-[(2e)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl]-.beta.-d-glucopyranosyl]oxy]-
[(2r,3s,4s,5r,6s)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-3-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate
NCGC00163634-01
bdbm50241244
kaempferol 3-o-(6'''' ''''-o-e-p-coumaroyl)-beta-d-glucopyranoside
(e)-((2r,3s,4s,5r,6s)-6-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-3-yloxy)-3,4,5-trihydroxy-tetrahydro-2h-pyran-2-yl)methyl 3-(4-hydroxyphenyl)acrylate
kaempferol-3-beta-d-(6-o-trans-p-coumaroyl)glucopyranoside
trans-tiliroside
chebi:80944 ,
CHEMBL266564 ,
C17140
[(2r,3s,4s,5r,6s)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate
15m04txr9m ,
unii-15m04txr9m
A814433
kaempferol-3-o(-6-o-trans-p-coumaroyl-.beta.-glucopyranoside
astragalin-6''-trans-p-coumarate
kaempferol 3-o-(6''-o-(e)-p-coumaroyl)-.beta.-d-glucopyranoside
kaempferol 3-o-.beta.-d-(6-o-trans-p-coumaroyl)glucopyranoside
3-o-kaempferol 6-o-(trans-p-coumaroyl)-.beta.-d-glucopyranoside
2-propenoic acid, 3-(4-hydroxyphenyl)-, 6'-ester with 3-(.beta.-d-glucopyranosyloxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one, (e)-
kaempferol 3-o-(6''-o-p-coumaroyl)glucoside
potengriffioside a
ronacare tiliroside
kaempferol 3-o-(6''-o-(trans-p-coumaroyl))-.beta.-d-glucopyranoside
4h-1-benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-((6-o-((2e)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl)-.beta.-d-glucopyranosyl)oxy)-
tiliroside [inci]
AKOS015896718
SCHEMBL23597
kaempferol-3-o-beta-d-(6''-(e)-p-coumaroyl)-glucopyranoside
5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4e-1-benzopyran-3-yl 6-o-[(2e)-3-(4-hydroxyphenyl)prop-2-enoyl]-beta-d-glucopyranoside
mfcd00017454
kaempferol 3-o-(6-o-p-coumaroyl)-glucoside
Q-100248
tiliroside, analytical standard
((2r,3s,4s,5r,6s)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)methyl 3-(4-hydroxyphenyl)acrylate
HY-N2443
((2r,3s,4s,5r,6s)-6-((5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)methyl (e)-3-(4-hydroxyphenyl)acrylate
(e)-((2r,3s,4s,5r,6s)-6-(5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-3-yloxy)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)methyl 3-(4-hydroxyphenyl)acrylate
Q23418844
CS-0022668
MS-30569
6''-o-trans-p-coumaroylastragalin
kaempferol-3-(p-coumaryl)glucoside
DTXSID601021936
GLXC-13144

Research Excerpts

Overview

Tiliroside is a natural flavonoid in multiple medicinal and dietary plants with known anti-inflammatory activities. Tiliro side is present in many plants species including Helicteres velutina K.

ExcerptReferenceRelevance
"Tiliroside is a glycosidic dietary flavonoid with pharmacological properties, including anti-cancer."( Tiliroside Combined with Anti-MUC1 Monoclonal Antibody as Promising Anti-Cancer Strategy in AGS Cancer Cells.
Bielawska, A; Galicka, A; Jakimiuk, K; Radziejewska, I; Supruniuk, K; Tomczyk, M, 2023
)
3.07
"Tiliroside is a natural flavonoid in multiple medicinal and dietary plants with known anti-inflammatory activities."( Tiliroside Attenuates NLRP3 Inflammasome Activation in Macrophages and Protects against Acute Lung Injury in Mice.
Deng, K; Lang, X; Li, M; Qiu, L; Yang, J; Yu, J; Zhang, J; Zhong, C; Zhong, G, 2023
)
3.07
"Tiliroside is a glycosidic flavonoid present in many plants species including Helicteres velutina K. "( Analysis of the toxicological and pharmacokinetic profile of Kaempferol-3-O-β-D-(6"-E-p-coumaryl) glucopyranoside - Tiliroside: in silico, in vitro and ex vivo assay.
Cordeiro, LV; Fernandes, DA; Ferreira, MDL; Oliveira Filho, AA; Pessoa, HLF; Sá, RCS; Sousa, AP; Souza, MFV, 2021
)
2.27

Actions

ExcerptReferenceRelevance
"Tiliroside was found to inhibit both monophenolase and diphenolase activity of mushroom tyrosinase. "( Tyrosinase inhibitory effect and inhibitory mechanism of tiliroside from raspberry.
Chen, J; Lu, YH; Tao, XY; Wang, ZT; Wei, DZ, 2009
)
2.04

Treatment

Tiliroside treatment suppressed intrarenal AGT, Renin, ACE, and Ang II. Treatment also suppressed hyperinsulinemia after starch administration. Treatment at 0.3 μg/mL slightly accentuated the total ceramide content in the SC.

ExcerptReferenceRelevance
"Tiliroside treatment suppressed intrarenal AGT, Renin, ACE, and Ang II, but upregulated intrarenal ACE2 and Ang1-7, without affecting plasma Ang II and Ang1-7 levels."( Tiliroside Protects against Lipopolysaccharide-Induced Acute Kidney Injury via Intrarenal Renin-Angiotensin System in Mice.
Song, S; Tang, L; Xu, C; Yang, H; Yang, J; Yi, X; Yu, J; Zhong, C, 2023
)
3.07
"Tiliroside treatment also suppressed hyperinsulinemia after starch administration."( Tiliroside, a glycosidic flavonoid, inhibits carbohydrate digestion and glucose absorption in the gastrointestinal tract.
Goto, T; Horita, M; Matsuura, Y; Nagai, H; Nagaoka, S; Nagatomo, A; Nishida, N, 2012
)
2.54
"Treatment with tiliroside at 0.3 μg/mL slightly accentuated the total ceramide content in the SC together with a significant increase in the ceramide [NS, NDS] content."( Strawberry seed extract and its major component, tiliroside, promote ceramide synthesis in the stratum corneum of human epidermal equivalents.
Imokawa, G; Shimoda, H; Takarada, T; Takeda, S, 2018
)
1.07
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
glycosyloxyflavoneA member of the class of flavones having one or more glycosyl residues attached at unspecified positions.
cinnamate ester
trihydroxyflavoneAny hydroxyflavone carrying three hydroxy groups at unspecified positions.
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
flavonol acylglucoside biosynthesis I - kaempferol derivatives09
flavonol acylglucoside biosynthesis I - kaempferol derivatives015

Protein Targets (9)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 12Homo sapiens (human)Ki0.13430.00021.10439.9000AID1254159
Carbonic anhydrase 1Homo sapiens (human)Ki10.00000.00001.372610.0000AID1254155
Carbonic anhydrase 2Homo sapiens (human)Ki10.00000.00000.72369.9200AID1254156
Cytochrome P450 3A4Homo sapiens (human)IC50 (µMol)0.70000.00011.753610.0000AID333514
TyrosinaseHomo sapiens (human)IC50 (µMol)78.53000.02304.459310.0000AID1891160
Carbonic anhydrase 4Homo sapiens (human)Ki5.46870.00021.97209.9200AID1254157
Carbonic anhydrase 7Homo sapiens (human)Ki0.00460.00021.37379.9000AID1254158
Xanthine dehydrogenase/oxidaseHomo sapiens (human)IC50 (µMol)100.00000.00132.81389.8200AID399340
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (72)

Processvia Protein(s)Taxonomy
estrous cycleCarbonic anhydrase 12Homo sapiens (human)
chloride ion homeostasisCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
melanin biosynthetic process from tyrosineTyrosinaseHomo sapiens (human)
eye pigment biosynthetic processTyrosinaseHomo sapiens (human)
visual perceptionTyrosinaseHomo sapiens (human)
cell population proliferationTyrosinaseHomo sapiens (human)
response to UVTyrosinaseHomo sapiens (human)
response to blue lightTyrosinaseHomo sapiens (human)
response to vitamin DTyrosinaseHomo sapiens (human)
melanin biosynthetic processTyrosinaseHomo sapiens (human)
thymus developmentTyrosinaseHomo sapiens (human)
response to cAMPTyrosinaseHomo sapiens (human)
pigmentationTyrosinaseHomo sapiens (human)
bicarbonate transportCarbonic anhydrase 4Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 4Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 7Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 7Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 7Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 7Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 7Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 7Homo sapiens (human)
allantoin metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of protein phosphorylationXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell proliferationXanthine dehydrogenase/oxidaseHomo sapiens (human)
guanine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
inosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyinosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
adenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyadenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyguanosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
AMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
IMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
lactationXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of gene expressionXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron-sulfur cluster assemblyXanthine dehydrogenase/oxidaseHomo sapiens (human)
amide catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell differentiationXanthine dehydrogenase/oxidaseHomo sapiens (human)
GMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dGMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dAMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of p38MAPK cascadeXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vascular endothelial growth factor signaling pathwayXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of reactive oxygen species metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vasculogenesisXanthine dehydrogenase/oxidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (40)

Processvia Protein(s)Taxonomy
zinc ion bindingCarbonic anhydrase 12Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 12Homo sapiens (human)
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
tyrosinase activityTyrosinaseHomo sapiens (human)
copper ion bindingTyrosinaseHomo sapiens (human)
protein bindingTyrosinaseHomo sapiens (human)
identical protein bindingTyrosinaseHomo sapiens (human)
protein homodimerization activityTyrosinaseHomo sapiens (human)
protein bindingCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 4Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 7Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 7Homo sapiens (human)
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron ion bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein homodimerization activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
FAD bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (28)

Processvia Protein(s)Taxonomy
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
membraneCarbonic anhydrase 12Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 12Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 12Homo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
cytoplasmTyrosinaseHomo sapiens (human)
lysosomeTyrosinaseHomo sapiens (human)
Golgi-associated vesicleTyrosinaseHomo sapiens (human)
melanosome membraneTyrosinaseHomo sapiens (human)
melanosomeTyrosinaseHomo sapiens (human)
intracellular membrane-bounded organelleTyrosinaseHomo sapiens (human)
perinuclear region of cytoplasmTyrosinaseHomo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 4Homo sapiens (human)
rough endoplasmic reticulumCarbonic anhydrase 4Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentCarbonic anhydrase 4Homo sapiens (human)
Golgi apparatusCarbonic anhydrase 4Homo sapiens (human)
trans-Golgi networkCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
external side of plasma membraneCarbonic anhydrase 4Homo sapiens (human)
cell surfaceCarbonic anhydrase 4Homo sapiens (human)
membraneCarbonic anhydrase 4Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 4Homo sapiens (human)
transport vesicle membraneCarbonic anhydrase 4Homo sapiens (human)
secretory granule membraneCarbonic anhydrase 4Homo sapiens (human)
brush border membraneCarbonic anhydrase 4Homo sapiens (human)
perinuclear region of cytoplasmCarbonic anhydrase 4Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
cytosolCarbonic anhydrase 7Homo sapiens (human)
cytoplasmCarbonic anhydrase 7Homo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
peroxisomeXanthine dehydrogenase/oxidaseHomo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
sarcoplasmic reticulumXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (119)

Assay IDTitleYearJournalArticle
AID1092160Antifungal activity against Ceratocystis paradoxa assessed as mycelial growth inhibition at 100 ug/disc after 2 to 4 days by disk diffusion method relative to control2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
A new antifungal and cytotoxic C-methylated flavone glycoside from Picea neoveitchii.
AID295593Effect on total plasma cholesterol in ddY mouse at 1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID609259Induction of osteogenesis in rat calvaria-derived primary osteoblasts assessed as increase in BMP2 mRNA level at 100 pM after 48 hrs by quantitative PCR analysis2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Osteogenic constituents from Pterospermum acerifolium Willd. flowers.
AID295576Effect on liver weight in ddY mouse at 10 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295546Effect on food intake in ddY mouse at 10 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID1377659Antimicrobial activity against Escherichia coli ATCC 25922 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID295559Reduction of paranephric fat in ddY mouse at 25 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295564Reduction of paranephric fat in ddY mouse at 10 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID399341Antioxidant activity assessed as superoxide-scavenging activity by nitrite method1998Journal of natural products, Jan, Volume: 61, Issue:1
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
AID619463Increase in glucose consumption in insulin-resistant human HepG2 cells after 24 hrs2011European journal of medicinal chemistry, Oct, Volume: 46, Issue:10
Synthesis and biological activity of novel tiliroside derivants.
AID295570Reduction of visceral fat in ddY mouse at 10 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID1377661Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID295584Effect on plasma triglyceride in ddY mouse at 50 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID1092159Cytotoxicity against Spodoptera litura cells assessed as growth inhibition at 20 mg/L after 24 hr by MTT assay relative to control2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
A new antifungal and cytotoxic C-methylated flavone glycoside from Picea neoveitchii.
AID1092161Antifungal activity against Alternaria mali assessed as mycelial growth inhibition at 100 ug/disk after 2 to 4 days by disk diffusion method relative to control2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
A new antifungal and cytotoxic C-methylated flavone glycoside from Picea neoveitchii.
AID609254Induction of osteogenesis in rat calvaria-derived primary osteoblasts assessed as increase in ALP activity at 10 pM after 48 hrs by bradford assay relative to control2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Osteogenic constituents from Pterospermum acerifolium Willd. flowers.
AID295560Reduction of paranephric fat in ddY mouse at 50 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID397122Inhibition of HIV1 RT
AID295580Effect on liver triglyceride in ddY mouse at 0.1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID1092163Antifungal activity against Magnaporthe grisea assessed as mycelial growth inhibition at 100 ug/disk after 2 to 4 days by disk diffusion method relative to control2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
A new antifungal and cytotoxic C-methylated flavone glycoside from Picea neoveitchii.
AID377952Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 20 hrs by MTT assay1999Journal of natural products, Jan, Volume: 62, Issue:1
Acylated flavonol glycosides from leaves of Stenochlaena palustris.
AID295587Effect on plasma triglyceride in ddY mouse at 1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID429277Inhibition of PLCgamma1 phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID429272Inhibition of ERK in DNP-BSA-stimulated rat RBL2H3 cells assessed as reduction in cPLA2 phosphorylation by Western blotting2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID295549Reduction of epididymal fat in ddY mouse at 12.5 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295588Effect on plasma triglyceride in ddY mouse at 10 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID395320Cytotoxicity against mouse Ehrlich carcinoma cells2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors.
AID1377662Antimicrobial activity against Acinetobacter baumannii ATCC 19606 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID399340Inhibition of xanthine oxidase assessed as decrease in uric acid production by spectrophotometry1998Journal of natural products, Jan, Volume: 61, Issue:1
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
AID295578Effect on liver triglyceride in ddY mouse at 50 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295566Reduction of visceral fat in ddY mouse at 50 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID1254159Inhibition of human recombinant carbonic anhydrase 12 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
AID295544Effect on food intake in ddY mouse at 0.1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295541Effect on food intake in ddY mouse at 25 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295562Reduction of paranephric fat in ddY mouse at 0.1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID395316Inhibition of Trypanosoma cruzi recombinant glycosomal GAPDH expressed in Escherichia coli by spectrophotometry2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors.
AID295567Reduction of visceral fat in ddY mouse at 12.5 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295591Effect on total plasma cholesterol in ddY mouse at 12.5 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID1254155Inhibition of human recombinant carbonic anhydrase 1 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
AID429188Inhibition of JNK phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID295558Reduction of mesenteric fat in ddY mouse at 10 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295552Reduction of epididymal fat in ddY mouse at 10 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295589Effect on total plasma cholesterol in ddY mouse at 25 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295573Effect on liver weight in ddY mouse at 12.5 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295577Effect on liver triglyceride in ddY mouse at 25 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295551Reduction of epididymal fat in ddY mouse at 1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295585Effect on plasma triglyceride in ddY mouse at 12.5 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID377951Antibacterial activity against Bacillus cereus ATCC 10702 after 20 hrs by MTT assay1999Journal of natural products, Jan, Volume: 62, Issue:1
Acylated flavonol glycosides from leaves of Stenochlaena palustris.
AID1891160Inhibition of tyrosinase (unknown origin)2022Bioorganic & medicinal chemistry letters, 06-01, Volume: 65Polyphenolic compounds: Synthesis, assessment of antimicrobial effect and enzymes inhibition against important medicinal enzymes with computational details.
AID295594Effect on total plasma cholesterol in ddY mouse at 10 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295598Effect on free fatty acid in ddY mouse plasma at 0.1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID294162Inhibition of diphenolase activity of mushroom tyrosinase at 0.056 mM2007Bioorganic & medicinal chemistry, Apr-01, Volume: 15, Issue:7
Identification of tyrosinase inhibitors from Marrubium velutinum and Marrubium cylleneum.
AID1377660Antimicrobial activity against Klebsiella pneumoniae ATCC 700603 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID295547Reduction of epididymal fat in ddY mouse at 25 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295550Reduction of epididymal fat in ddY mouse at 0.1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295565Reduction of visceral fat in ddY mouse at 25 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID429274Antiallergic activity in IgE-sensitized DNP-BSA-stimulated rat RBL2H3 cells assessed as decrease in intracellular Ca2+ level by fluorimetry2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID295583Effect on plasma triglyceride in ddY mouse at 25 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID609262Induction of mineralization in rat femur-derived bone marrow cells at 100 pM after 21 days by Alizarin Red S staining2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Osteogenic constituents from Pterospermum acerifolium Willd. flowers.
AID295553Reduction of mesenteric fat in ddY mouse at 25 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID429273Antiallergic activity in IgE-sensitized rat RBL2H3 cells assessed as inhibition of A-23187-stimulated beta hexaminidase release relative to control2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID295582Effect on liver triglyceride in ddY mouse at 10 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295571Effect on liver weight in ddY mouse at 25 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID1092162Antifungal activity against Athelia rolfsii assessed as mycelial growth inhibition at 100 ug/disk after 2 to 4 days by disk diffusion method relative to control2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
A new antifungal and cytotoxic C-methylated flavone glycoside from Picea neoveitchii.
AID295586Effect on plasma triglyceride in ddY mouse at 0.1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295581Effect on liver triglyceride in ddY mouse at 1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295595Effect on free fatty acid in ddY mouse plasma at 25 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295554Reduction of mesenteric fat in ddY mouse at 50 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID1254158Inhibition of human recombinant carbonic anhydrase 7 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
AID333514Inhibition of human CYP3A42004Journal of natural products, Nov, Volume: 67, Issue:11
Isolation of cytochrome P450 inhibitors from strawberry fruit, Fragaria ananassa.
AID377953Antibacterial activity against Staphylococcus aureus ATCC 25923 after 20 hrs by MTT assay1999Journal of natural products, Jan, Volume: 62, Issue:1
Acylated flavonol glycosides from leaves of Stenochlaena palustris.
AID295597Effect on free fatty acid in ddY mouse plasma at 12.5 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295556Reduction of mesenteric fat in ddY mouse at 0.1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID429278Antiallergic activity in IgE-sensitized rat RBL2H3 cells assessed as inhibition of DNP-BSA-stimulated beta hexaminidase release relative to control2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID295600Effect on free fatty acid in ddY mouse plasma at 10 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID429187Inhibition of ERK phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID295563Reduction of paranephric fat in ddY mouse at 1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID609258Cytotoxicity against rat calvaria-derived primary osteoblasts assessed as cell viability by MTT assay2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Osteogenic constituents from Pterospermum acerifolium Willd. flowers.
AID295601Effect on D-glucose level in ddY mouse plasma at 0.1 to 10 mg/kg/day for 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID609261Induction of osteogenesis in rat calvaria-derived primary osteoblasts assessed as increase in Col1 mRNA level at 100 pM after 48 hrs by quantitative PCR analysis2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Osteogenic constituents from Pterospermum acerifolium Willd. flowers.
AID295542Effect on food intake in ddY mouse at 50 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID429275Antioxidant activity in IgE-sensitized rat RBL2H3 cells assessed as reduction in DNP-BSA-mediated intracellular ROS production at 50 uM after 30 mins by fluorimetry2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID429276Inhibition of PLCgamma2 phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID295561Reduction of paranephric fat in ddY mouse at 12.5 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID429185Antioxidant activity assessed as radical DPPH scavenging activity2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID609260Induction of osteogenesis in rat calvaria-derived primary osteoblasts assessed as increase in runx2 mRNA level at 100 pM after 48 hrs by quantitative PCR analysis2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Osteogenic constituents from Pterospermum acerifolium Willd. flowers.
AID295543Effect on food intake in ddY mouse at 12.5 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295555Reduction of mesenteric fat in ddY mouse at mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID1377664Antimicrobial activity against Cryptococcus neoformans ATCC 208821 at 32 ug/ml after 24 hrs by resazurin dye based assay2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID609256Induction of osteogenesis in rat calvaria-derived primary osteoblasts assessed as increase in ALP activity at 1 nM to 1 uM after 48 hrs by bradford assay relative to control2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Osteogenic constituents from Pterospermum acerifolium Willd. flowers.
AID429271Inhibition of p38 phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID377954Antibacterial activity against Micrococcus luteus ATCC 9341 after 20 hrs by MTT assay1999Journal of natural products, Jan, Volume: 62, Issue:1
Acylated flavonol glycosides from leaves of Stenochlaena palustris.
AID295592Effect on total plasma cholesterol in ddY mouse at 0.1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295602Increase in expression of PPAR alpha mRNA level in liver tissue of orally dosed ddY mouse, after 24 hrs2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID609255Induction of osteogenesis in rat calvaria-derived primary osteoblasts assessed as increase in ALP activity at 100 pM after 48 hrs by bradford assay relative to control2011Bioorganic & medicinal chemistry letters, Aug-01, Volume: 21, Issue:15
Osteogenic constituents from Pterospermum acerifolium Willd. flowers.
AID1377658Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 at 32 ug/ml after 18 hrs2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID1254157Inhibition of human recombinant carbonic anhydrase 4 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
AID429186Inhibition of Syk phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID295572Effect on liver weight in ddY mouse at 50 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295590Effect on total plasma cholesterol in ddY mouse at 50 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295596Effect on free fatty acid in ddY mouse plasma at 50 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID395319Antileishmanial activity against Leishmania amazonensis amastigote forms at 841 uM2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors.
AID295557Reduction of mesenteric fat in ddY mouse at 1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID395318Antitrypanosomal activity against Trypanosoma cruzi amastigote forms at 841 uM2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors.
AID295599Effect on free fatty acid in ddY mouse plasma at 1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295574Effect on liver weight in ddY mouse at 0.1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295548Reduction of epididymal fat in ddY mouse at 50 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295569Reduction of visceral fat in ddY mouse at 1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID295579Effect on liver triglyceride in ddY mouse at 12.5 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID294163Inhibition of diphenolase activity of mushroom tyrosinase at 0.011 mM2007Bioorganic & medicinal chemistry, Apr-01, Volume: 15, Issue:7
Identification of tyrosinase inhibitors from Marrubium velutinum and Marrubium cylleneum.
AID295545Effect on food intake in ddY mouse at 1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID1377663Antimicrobial activity against Candida albicans ATCC 90028 at 32 ug/ml after 24 hrs by resazurin dye based assay2017Journal of natural products, 07-28, Volume: 80, Issue:7
Phytochemical Studies on Two Australian Anigozanthos Plant Species.
AID1254156Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
AID295568Reduction of visceral fat in ddY mouse at 0.1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID400608Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs1996Journal of natural products, Mar, Volume: 59, Issue:3
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
AID295575Effect on liver weight in ddY mouse at 1 mg/kg/day, po after 14 to 15 days2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (87)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.15)18.7374
1990's5 (5.75)18.2507
2000's21 (24.14)29.6817
2010's41 (47.13)24.3611
2020's19 (21.84)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.20 (24.57)
Research Supply Index4.53 (2.92)
Research Growth Index5.49 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other92 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]